You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 18, 2024

CEDAX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Cedax patents expire, and when can generic versions of Cedax launch?

Cedax is a drug marketed by Si Pharms and is included in two NDAs.

The generic ingredient in CEDAX is ceftibuten dihydrate. Additional details are available on the ceftibuten dihydrate profile page.

Summary for CEDAX
US Patents:0
Applicants:1
NDAs:2
Raw Ingredient (Bulk) Api Vendors: 46
Patent Applications: 4,636
What excipients (inactive ingredients) are in CEDAX?CEDAX excipients list
DailyMed Link:CEDAX at DailyMed
Drug patent expirations by year for CEDAX

US Patents and Regulatory Information for CEDAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Si Pharms CEDAX ceftibuten dihydrate CAPSULE;ORAL 050685-002 Dec 20, 1995 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Si Pharms CEDAX ceftibuten dihydrate FOR SUSPENSION;ORAL 050686-001 Dec 20, 1995 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Si Pharms CEDAX ceftibuten dihydrate FOR SUSPENSION;ORAL 050686-002 Dec 20, 1995 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CEDAX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Si Pharms CEDAX ceftibuten dihydrate FOR SUSPENSION;ORAL 050686-002 Dec 20, 1995 ⤷  Try a Trial ⤷  Try a Trial
Si Pharms CEDAX ceftibuten dihydrate CAPSULE;ORAL 050685-002 Dec 20, 1995 ⤷  Try a Trial ⤷  Try a Trial
Si Pharms CEDAX ceftibuten dihydrate FOR SUSPENSION;ORAL 050686-001 Dec 20, 1995 ⤷  Try a Trial ⤷  Try a Trial
Si Pharms CEDAX ceftibuten dihydrate FOR SUSPENSION;ORAL 050686-001 Dec 20, 1995 ⤷  Try a Trial ⤷  Try a Trial
Si Pharms CEDAX ceftibuten dihydrate FOR SUSPENSION;ORAL 050686-002 Dec 20, 1995 ⤷  Try a Trial ⤷  Try a Trial
Si Pharms CEDAX ceftibuten dihydrate FOR SUSPENSION;ORAL 050686-001 Dec 20, 1995 ⤷  Try a Trial ⤷  Try a Trial
Si Pharms CEDAX ceftibuten dihydrate CAPSULE;ORAL 050685-002 Dec 20, 1995 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for CEDAX

See the table below for patents covering CEDAX around the world.

Country Patent Number Title Estimated Expiration
Philippines 24474 A CRYSTALLINE HYDRATE OF ORAL CEPHALOSPORIN ⤷  Try a Trial
Ireland 842524 ⤷  Try a Trial
Canada 2134467 ⤷  Try a Trial
Czechoslovakia 8407528 ⤷  Try a Trial
South Korea 950005302 ⤷  Try a Trial
Germany 3745094 Ein kristallines Hydrat der 7ß-[(Z)-2-(2-Aminothiazol-4-yl)-4-carboxybut-2-enoylamino]-3-cephem-4-carbonsäure enthaltende Hartgelatinekapsel-Zusammensetzung (New stable hydrate of 7-butenoyl:amino- cephalosporin derivs. - esp. formulated in soft gelatin capsules sealed with gelatin layer) ⤷  Try a Trial
Hungary T36129 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for CEDAX

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0136721 95C0002 Belgium ⤷  Try a Trial PRODUCT NAME: CEFTIBUTEN + SURDOSAGE DE 8% ; NAT REG.: 304 S 146 FO 19941222; FIRST REG.: IT 0 27 84 9052 19920303
0136721 95C0003 Belgium ⤷  Try a Trial PRODUCT NAME: CEFTIBUTEN.; NAT REG.: 304 S 144 F5 19941222; FIRST REG.: IT 0 27 84 9025 19920303
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.